Clinuvel Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 May 24 | BuyAU$49,796 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 3,292 | AU$15.35 | |
20 May 24 | SellAU$108,527 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 7,181 | AU$15.43 | |
09 May 24 | SellAU$617,496 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 40,983 | AU$15.42 | |
08 May 24 | BuyAU$136,401 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 9,029 | AU$15.49 | |
23 Apr 24 | BuyAU$79,703 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 5,304 | AU$15.81 | |
23 Apr 24 | SellAU$865,136 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 56,759 | AU$15.90 | |
04 Apr 24 | BuyAU$1,134,874 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 80,349 | AU$16.18 | |
04 Apr 24 | SellAU$1,734,906 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 120,306 | AU$14.42 | |
01 Mar 24 | BuyAU$2,751,897 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 200,309 | AU$14.18 | |
01 Mar 24 | SellAU$2,836,865 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 203,327 | AU$14.32 | |
23 Feb 24 | BuyAU$9,140,350 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 587,087 | AU$18.05 | |
22 Feb 24 | SellAU$8,419,770 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 519,035 | AU$18.10 | |
19 Sep 23 | BuyAU$29,814 | Philippe Wolgen | Individual | 1,850 | AU$16.12 | |
26 Jun 23 | BuyAU$27,147 | Philippe Wolgen | Individual | 1,532 | AU$17.72 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,351,163 | 6.69% |
Individual Insiders | 6,812,612 | 13.6% |
Institutions | 10,315,951 | 20.6% |
General Public | 29,612,039 | 59.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,854,042 | AU$60.2m | -10.3% | 0.01% | |||
3,425,222 | AU$53.5m | 0% | no data | |||
2,590,824 | AU$40.5m | 0% | no data | |||
1,974,148 | AU$30.8m | 0% | no data | |||
1,743,118 | AU$27.2m | 0% | no data | |||
1,294,298 | AU$20.2m | -20% | 0.01% | |||
833,087 | AU$13.0m | 24.4% | no data | |||
670,756 | AU$10.5m | 46% | no data | |||
603,447 | AU$9.4m | 0% | no data | |||
539,139 | AU$8.4m | 1.62% | no data | |||
440,085 | AU$6.9m | 0% | no data | |||
358,254 | AU$5.6m | 0% | no data | |||
229,600 | AU$3.6m | 0% | no data | |||
200,582 | AU$3.1m | -14.9% | no data | |||
187,000 | AU$2.9m | 0% | no data | |||
179,480 | AU$2.8m | 0% | no data | |||
178,588 | AU$2.8m | 0% | no data | |||
156,892 | AU$2.5m | 0% | no data | |||
156,874 | AU$2.5m | 0% | no data | |||
146,000 | AU$2.3m | 0% | no data | |||
116,577 | AU$1.8m | 0% | no data | |||
85,737 | AU$1.3m | 0.17% | no data | |||
80,000 | AU$1.2m | 0% | no data | |||
72,635 | AU$1.1m | 0% | no data | |||
61,627 | AU$962.6k | 0.15% | no data |